138 related articles for article (PubMed ID: 35052458)
1. Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period.
Acevedo LAU; Alvarenga AM; Fonseca PFS; da Silva NK; Cançado RD; Naoum FA; Dinardo CL; Pereira AC; Brissot P; Santos PCJL
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052458
[TBL] [Abstract][Full Text] [Related]
2. Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis.
Fonseca PFS; Cançado RD; Naoum FA; Dinardo CL; Fonseca GHH; Gualandro SFM; Krieger JE; Pereira AC; Brissot P; Santos PCJL
BMC Med Genet; 2018 Jan; 19(1):3. PubMed ID: 29301508
[TBL] [Abstract][Full Text] [Related]
3. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women.
Warne CD; Zaloumis SG; Bertalli NA; Delatycki MB; Nicoll AJ; McLaren CE; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ; Gurrin LC;
J Gastroenterol Hepatol; 2017 Apr; 32(4):797-802. PubMed ID: 27784128
[TBL] [Abstract][Full Text] [Related]
4. GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
Levstik A; Stuart A; Adams PC
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
[TBL] [Abstract][Full Text] [Related]
5. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.
Viveiros A; Schaefer B; Panzer M; Henninger B; Plaikner M; Kremser C; Franke A; Franzenburg S; Hoeppner MP; Stauder R; Janecke A; Tilg H; Zoller H
Hepatology; 2021 Nov; 74(5):2424-2435. PubMed ID: 34048062
[TBL] [Abstract][Full Text] [Related]
6. Hereditary hemochromatosis.
Crownover BK; Covey CJ
Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762
[TBL] [Abstract][Full Text] [Related]
7. Transient elevation of serum ferritin in a Sri Lankan with homozygosity for H63D mutation in the HFE gene: a case report.
Wickramasinghe W; Karunathilaka C; Jayasinghe S; Gooneratne L
J Med Case Rep; 2020 Jul; 14(1):93. PubMed ID: 32641120
[TBL] [Abstract][Full Text] [Related]
8. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
[TBL] [Abstract][Full Text] [Related]
9. Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study.
Jacobs EM; Hendriks JC; van Deursen CT; Kreeftenberg HG; de Vries RA; Marx JJ; Stalenhoef AF; Verbeek AL; Swinkels DW
J Hepatol; 2009 Jan; 50(1):174-83. PubMed ID: 19008010
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
11. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of hereditary hemochromatosis: an update.
Kanwar P; Kowdley KV
Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):517-30. PubMed ID: 23985001
[TBL] [Abstract][Full Text] [Related]
13. Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance.
Milet J; Dehais V; Bourgain C; Jouanolle AM; Mosser A; Perrin M; Morcet J; Brissot P; David V; Deugnier Y; Mosser J
Am J Hum Genet; 2007 Oct; 81(4):799-807. PubMed ID: 17847004
[TBL] [Abstract][Full Text] [Related]
14.
Sandnes M; Vorland M; Ulvik RJ; Reikvam H
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440336
[No Abstract] [Full Text] [Related]
15. A primer for predicting risk of disease in HFE-linked hemochromatosis.
Adams PC; Walker AP; Acton RT
Genet Test; 2001; 5(4):311-6. PubMed ID: 11960576
[TBL] [Abstract][Full Text] [Related]
16. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
17. Do pregnancies reduce iron overload in HFE hemochromatosis women? results from an observational prospective study.
Scotet V; Saliou P; Uguen M; L'Hostis C; Merour MC; Triponey C; Chanu B; Nousbaum JB; Le Gac G; Ferec C
BMC Pregnancy Childbirth; 2018 Feb; 18(1):53. PubMed ID: 29454332
[TBL] [Abstract][Full Text] [Related]
18. Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study.
Lim A; Speechley M; Adams PC
Can J Gastroenterol Hepatol; 2014 Oct; 28(9):502-4. PubMed ID: 25314357
[TBL] [Abstract][Full Text] [Related]
19. Association of frequency of hereditary hemochromatosis (HFE) gene mutations (H63D and C282Y) with iron overload in beta-thalassemia major patients in Pakistan.
Sharif Y; Irshad S; Tariq A; Rasheed S; Tariq MH
Saudi Med J; 2019 Sep; 40(9):887-892. PubMed ID: 31522215
[TBL] [Abstract][Full Text] [Related]
20. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria.
Adams PC; Chakrabarti S
Gastroenterology; 1998 Feb; 114(2):319-23. PubMed ID: 9453492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
